Effectiveness and safety of insulin glargine detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis

about

Effectiveness and safety of insulin glargine detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis

Item

http://www.wikidata.org/entity/Q58817760

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effectiveness and safety of in ...... matic review and meta-analysis

@en

Effectiveness and safety of in ...... matic review and meta-analysis

@nl

type

Item

label

Effectiveness and safety of in ...... matic review and meta-analysis

@en

Effectiveness and safety of in ...... matic review and meta-analysis

@nl

prefLabel

Effectiveness and safety of in ...... matic review and meta-analysis

@en

Effectiveness and safety of in ...... matic review and meta-analysis

@nl

P1476

Effectiveness and safety of in ...... matic review and meta-analysis

@en

P2093

Augusto A Guerra Júnior

http://www.w3.org/2001/XMLSchema#string

Francisco de Assis Acurcio

http://www.w3.org/2001/XMLSchema#string

Juliana Alvares

http://www.w3.org/2001/XMLSchema#string

Paulo H R F Almeida

http://www.w3.org/2001/XMLSchema#string

Thales B C Silva

http://www.w3.org/2001/XMLSchema#string

Vania E Araújo

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin detemir versus insulin glargine for type 2 diabetes mellitus

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.

P304

241-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042018818781414

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian Godman

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30181850

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

Insulin

P932

6116758

http://www.w3.org/2001/XMLSchema#string